CD44 and neoplasm: As shown inFigure 2C, activity of the CD44 along with proteoglycanhyaluronan (HA) in MAPK signaling pathway is associatedwith growth and survival of tumor cells [P=1.5×10-6, falsediscovery rate (FDR) correction=0.0002].